Giving people hope
There have been some recent breakthroughs in lung cancer treatments, which are giving people hope. We’ve seen an increase in survival rates for a small group of patients. While this is encouraging, we urgently need more research to:
- Improve these and other treatments
- Help diagnose lung cancer earlier
- Provide better support for people’s mental well-being
- Find a cure.
Our plan for change
“The Next Breath: Accelerating Lung Cancer Reform in Australia 2022-2025“ is a blueprint that highlights the urgent issues in lung cancer. It shows where government investment is needed and where we need to work together nationally. This plan provides a way to make significant changes that can improve lung cancer care and save lives.
Supporting lung cancer research and clinical trials
We’re committed to improving the outcomes and quality of life for people with lung cancer. We do this by driving more focused research and by supporting:
- A well-known clinical trials program that’s recognised around the world
- A range of grants and awards for lung cancer research through our Hope Research grants and awards program. These awards and grants support important research into how we diagnose, treat, and manage lung cancer.
Meet our researchers
A/Prof Lucy Morgan
Mucociliary clearance, developing a new way of measuring clearance for patients impacted by Chronic Obstructive Pulmonary Disease (COPD)
Dr Ian Yang
Identifying the microRNAs associated with histomorphological chronic lung disease from smoking
Dr Casey Ah-Cann
Identification of novel epigenetic regulators of lung development and lung cancer
Dr Tan Nguyen
Inhibition of RNAutophagy as a novel therapeutic strategy in lung cancer
Angela Burge
Interventions for promoting physical activity in people with Chronic Obstructive Pulmonary Disease
Dr Clare Weeden
Deep profiling of lung cancer, metastasis and the immune system to identify novel therapeutic targets
Dr Atiqur Rahman
Elucidating and targeting genomic and epigenetic changes in the development and progression of lung cancer
Dr Christian Osadnik
Towards tailored rehabilitation for COPD exacerbation phenotypes: looking back for the future
Jade Jaffar
Identification of Perfenidone – responsive patients with IDF by high-throughput in-vitro screening
Tylah Miles
Immune regulation of Idiopathic Pulmonary Fibrosis
Dr Anna Hudson
Detection of neural impairments in respiratory motor control in Chronic Obstructive Pulmonary Disease
Priyanka Sahu
Elucidating and targeting genomic and epigenetic changes in the development and progression of lung cancer
Dr Richard Kim
Investigating the roles, therapeutic targeting and clinical relevance of microRNAs in COPD
Dr Yet Hong Khor
Novel methods to distinguish idiopathic pulmonary fibrosis from connective tissue disease-associated interstitial lung disease
Dr Yet Hong Khor
Improving symptomatic care for ILD – Look ahead and beyond Oxygen Therapy
Dr Venessa Chin
Utilising single cell sequencing to change the management of lung cancer
Dr Afaf Abed
Using biomarkers to understand an individual’s responsiveness to immunotherapy
Dr Laura Glenn
Novel diagnostic techniques in Interstitial Lung Disease
Dr Simone De Luca
New ways to treat vascular cognitive impairment and dementia in chronic lung disease
Dr Arwel Jones
Exercise for Exacerbations and Rhinovirus Treatment
Dr. Caitlin Fermoyle
Precision Medicine in Pulmonary Fibrosis
Help shine a light on lung cancer
You can help raise awareness and fund life-changing research for people living with lung cancer in Australia. There are many ways to get involved:
- Host a local “Shine a light on lung cancer” community event
- Attend or donate to an event
- Simply set up a fundraising page.
Helpful links
Was this page helpful?
Good job! Please give your positive feedback
How could we improve this post? Please Help us.
